Mirna Toledo‐Bahena

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · JAMA Dermatology · 2022 · 43 citations · Full text

Medicine, Dermatology, Pediatrics +13

Long‐term efficacy and safety of infliximab maintenance therapy in patients with plaque‐type psoriasis in real‐world practice

Neil H. Shear, Morghan Hartmann, Mirna Toledo‐Bahena et al. · British Journal of Dermatology · 2014 · 35 citations

Medicine, Dermatology, Pharmacotherapy +9

Biallelic variants in <i>RNU12</i> cause CDAGS syndrome

Chao Xing, Mohammed Kanchwala, Jonathan J. Rios et al. · Human Mutation · 2021 · 28 citations

Life Sciences, Genetics, Molecular Genetics +17

Pityriasis Versicolor in Children and Adolescents: an Update

Karen Adilene Camargo-Sánchez, Mirna Toledo‐Bahena, Carlos Mena‐Cedillos et al. · Current Fungal Infection Reports · 2019 · 26 citations

Medicine, Dermatology, Pediatrics +8

The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.

Mirna Toledo‐Bahena, A Bucko, Jorge Ocampo‐Candiani et al. · PubMed · 2014 · 17 citations

Health Professions, Dermatology, Pharmacotherapy +17